SHP-1: the next checkpoint target for cancer immunotherapy?
about
Alteration of SHP-1/p-STAT3 Signaling: A Potential Target for Anticancer Therapy.Purity of transferred CD8(+) T cells is crucial for safety and efficacy of combinatorial tumor immunotherapy in the absence of SHP-1.Shp1 function in myeloid cells.Mining the Complex Family of Protein Tyrosine Phosphatases for Checkpoint Regulators in Immunity.Incorporation of Immune Checkpoint Blockade into Chimeric Antigen Receptor T Cells (CAR-Ts): Combination or Built-In CAR-T.Vanadium: A Panacea for Resistance to Oncolytic Immunotherapy?
P2860
SHP-1: the next checkpoint target for cancer immunotherapy?
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
SHP-1: the next checkpoint target for cancer immunotherapy?
@en
type
label
SHP-1: the next checkpoint target for cancer immunotherapy?
@en
prefLabel
SHP-1: the next checkpoint target for cancer immunotherapy?
@en
P2860
P921
P356
P1476
SHP-1: the next checkpoint target for cancer immunotherapy?
@en
P2093
James Matthews
Sophie Wehenkel
P2860
P304
P356
10.1042/BST20150251
P5008
P577
2016-04-01T00:00:00Z
2016-04-15T00:00:00Z